Caption Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,000
Closed -$7.62M 1687
2025
Q4
$7.62M Hold
75,000
0.05% 400
2025
Q3
$4.1M Buy
75,000
+17,000
+29% +$849K 0.03% 568
2025
Q2
$3.08M Buy
+58,000
New +$2.95M 0.03% 575
2025
Q1
Sell
-226,800
Closed -$12.7M 1676
2024
Q4
$12.7M Buy
+226,800
New +$14.1M 0.12% 147
2024
Q2
Sell
-172,500
Closed -$11.9M 1266
2024
Q1
$11.9M Sell
172,500
-302,000
-64% -$19.1M 0.18% 129
2023
Q4
$35.1M Buy
474,500
+118,300
+33% +$7.75M 0.47% 34
2023
Q3
$24.3M Sell
356,200
-334,200
-48% -$28.4M 0.37% 51
2023
Q2
$64.8M Buy
690,400
+307,600
+80% +$24M 1.15% 8
2023
Q1
$26M Sell
382,800
-32,800
-8% -$2.11M 0.5% 45
2022
Q4
$20.6M Buy
415,600
+63,600
+18% +$2.6M 0.32% 65
2022
Q3
$11.4M Buy
352,000
+302,000
+604% +$12.5M 0.16% 142
2022
Q2
$1.97M Sell
50,000
-10,600
-17% -$567K 0.03% 672
2022
Q1
$4.24M Buy
60,600
+20,000
+49% +$1.46M 0.05% 488
2021
Q4
$3.16M Buy
+40,600
New +$3.58M 0.04% 622
2021
Q1
Sell
-63,600
Closed -$8.42M 1151
2020
Q4
$8.42M Buy
63,600
+48,600
+324% +$5.88M 0.19% 148
2020
Q3
$1.53M Buy
+15,000
New +$1.3M 0.04% 514
2020
Q1
Sell
-345,300
Closed -$31.9M 914
2019
Q4
$31.9M Buy
345,300
+186,500
+117% +$16.4M 1.07% 9
2019
Q3
$14.3M Buy
158,800
+25,000
+19% +$2.85M 0.75% 26
2019
Q2
$15.8M Sell
133,800
-25,000
-16% -$2.52M 0.8% 20
2019
Q1
$13.8M Sell
158,800
-198,800
-56% -$16.9M 0.76% 19
2018
Q4
$22.6M Buy
+357,600
New +$24.5M 1.8% 4
2018
Q1
Sell
-200,000
Closed -$10.5M 248
2017
Q4
$10.5M Buy
+200,000
New +$10.7M 1.09% 25

Other funds holding EXAS

Caption Management's EXAS Position: Q1 2026 in Review

Caption Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 170,679 shares — an estimated $17.3M sold.

Caption Management first reported a position in EXAS in Q4 2018 and held it in 14 quarters. The position peaked at $17.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Caption Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 170,679 Exact Sciences shares in Q1 2026, an estimated $17.3M.
  • Caption Management first reported a position in Exact Sciences in Q4 2018 and held it in 14 quarters.
  • Caption Management's Exact Sciences position peaked at $17.3M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.